Results 151 to 160 of about 2,479 (207)

Fremanezumab for the treatment of migraine

Pain Management
Dimos Mitsikostas, Srdjan Ljubisavljevic
openaire   +1 more source

A retrospective audit of the real-world safety and effectiveness profile of eptinezumab for treatment-resistant chronic migraine in Australia. [PDF]

Headache
Gunasekera L, Cheng S, Foster E, Sivathamboo S, O'Brien T, Butzkueven H, Kulkarni J, Hutton E.   +7 more
europepmc   +1 more source

Multiple Sclerosis With Migraine and Pyoderma Gangrenosum Treated With Ofatumumab and Erenumab. [PDF]

Cureus
Motegi H, Komatsu T, Onda A, Sakai K, Iguchi Y.   +4 more
europepmc   +1 more source

Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab. [PDF]

Headache
Nikitina V, Santi Laurini G, Montanaro N, Motola D.   +3 more
europepmc   +1 more source

Is there a role of calcitonin gene-related peptide in cortical spreading depression mechanisms?- argument con. [PDF]

J Headache Pain
Melo-Carrillo A.
europepmc   +1 more source

US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review. [PDF]

Adv Ther
Eugeni P, Rooney ME, Saikali NP, Niu Z, Driessen MT, Krasenbaum LJ, Carr K, Seminerio MJ, McVige JW.   +8 more
europepmc   +1 more source

Time-series clustering analysis for treatment pattern of lasmiditan for 2 years from the initial prescription. [PDF]

Ther Adv Neurol Disord
Katsuki M, Yamada Y, Ichihara T, Matsumori Y.   +3 more
europepmc   +1 more source

Evaluating Treatment Success in CGRP Antibody Prophylaxis: A Retrospective Cohort Study Comparing Monthly Migraine Days, MIDAS Scores, and HIT-6 Scores. [PDF]

Pain Ther
Göbel CH, Heinze A, Heinze-Kuhn K, Müller U, Cirkel A, Göbel H.   +5 more
europepmc   +1 more source

Error in Figure.

JAMA Neurol
europepmc   +1 more source